Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

18.85
-0.1400-0.74%
Volume:80.88K
Turnover:1.54M
Market Cap:1.28B
PE:-17.46
High:19.51
Open:19.24
Low:18.62
Close:18.99
52wk High:26.30
52wk Low:12.56
Shares:67.77M
Float Shares:17.44M
Volume Ratio:0.66
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0799
EPS(LYR):-1.0800
ROE:-74.45%
ROA:-42.37%
PB:15.84
PE(LYR):-17.45

Loading ...

A Look At Pulse Biosciences (PLSE) Valuation After Its Recent Share Price Surge

Simply Wall St.
·
Feb 09

Pulse Biosciences Inc. Files Initial Beneficial Ownership Statement for Director Maria Sainz

Reuters
·
Feb 07

Top Midday Gainers

MT Newswires Live
·
Feb 07

Sector Update: Health Care Stocks Rise in Afternoon Trading

MT Newswires Live
·
Feb 07

Pulse Biosciences Reports Strong nPulse Atrial Fibrillation Study Results

TIPRANKS
·
Feb 06

Pulse Biosciences präsentiert erfolgreiche Studiendaten zum nPulse Cardiac Catheter System bei Vorhofflimmern

Reuters
·
Feb 06

Pulse Biosciences Inc. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht

Reuters
·
Feb 05

Pulse Biosciences Reports Positive 12-Month Data for Nanosecond PFA Catheter in Atrial Fibrillation Study

Reuters
·
Feb 03

Mizuho Securities Initiates Coverage on Pulse Biosciences With Outperform Rating

MT Newswires Live
·
Jan 30

Pulse Biosciences Inc : Mizuho Initiates Coverage With Outperform Rating; Target Price $25

THOMSON REUTERS
·
Jan 30

Pulse Biosciences initiated with an Outperform at Mizuho

TIPRANKS
·
Jan 30

New Cardiac Ablation Data and Board Appointment Might Change The Case For Investing In Pulse Biosciences (PLSE)

Simply Wall St.
·
Jan 13

Assessing Pulse Biosciences (PLSE) Valuation After Upcoming nPulse Cardiac Study Data Presentation

Simply Wall St.
·
Jan 09

Pulse Biosciences Appoints Maria Sainz to Board of Directors

Reuters
·
Jan 09

Pulse Biosciences Unveils Late-Breaking Data from nPulse Cardiac Catheter Study at AF Symposium

Reuters
·
Jan 06

Pulse Biosciences to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 30, 2025

Why Pulse Biosciences (PLSE) Is Up 8.0% After FDA Clears Pivotal Atrial Fibrillation Trial

Simply Wall St.
·
Dec 23, 2025

BRIEF-Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Dec 20, 2025

Pulse Biosciences Grants Inducement Stock Options to New Employees

Reuters
·
Dec 20, 2025

Pulse Biosciences Wins FDA IDE Approval for nPulse Cardiac Catheter Study

Reuters
·
Dec 18, 2025